Showing 12,541 - 12,560 results of 24,296 for search '(( a step decrease ) OR ( 100 ((mean decrease) OR (((teer decrease) OR (a decrease)))) ))', query time: 0.92s Refine Results
  1. 12541
  2. 12542

    Protection by extra virgin olive oil against oxidative stress <i>in vitro</i> and <i>in vivo</i>. Chemical and biological studies on the health benefits due to a major component of... by Miriam Rossi (201573)

    Published 2017
    “…In addition, EVOO significantly decreased the proliferation of human leukemic THP-1 cells, while it kept the proliferation at about normal levels in rat L6 myoblasts, a non-tumoral skeletal muscle cell line. …”
  3. 12543
  4. 12544
  5. 12545

    Table_1_Dynamic Changes of Cytokine Profiles and Virological Markers Associated With HBsAg Loss During Peginterferon Alpha-2a Treatment in HBeAg-Positive Chronic Hepatitis B Patien... by Minghui Li (409892)

    Published 2022
    “…HBsAg disappearance rate was the primary evaluation index at 48 weeks of PEG-IFN treatment.</p>Results<p>Among 100 patients who completed the 48-week PEG-IFN α-2a treatment, 38 patients achieved serum HBeAg disappearance, 25 patients achieved HBeAg seroconversion, 9 patients achieved functional cure, 37 patients had HBsAg decline of ≥1 log IU/ml, and 8 patients produced hepatitis B surface antibody (HBsAb). …”
  6. 12546

    Table_3_Dynamic Changes of Cytokine Profiles and Virological Markers Associated With HBsAg Loss During Peginterferon Alpha-2a Treatment in HBeAg-Positive Chronic Hepatitis B Patien... by Minghui Li (409892)

    Published 2022
    “…HBsAg disappearance rate was the primary evaluation index at 48 weeks of PEG-IFN treatment.</p>Results<p>Among 100 patients who completed the 48-week PEG-IFN α-2a treatment, 38 patients achieved serum HBeAg disappearance, 25 patients achieved HBeAg seroconversion, 9 patients achieved functional cure, 37 patients had HBsAg decline of ≥1 log IU/ml, and 8 patients produced hepatitis B surface antibody (HBsAb). …”
  7. 12547

    Table_2_Dynamic Changes of Cytokine Profiles and Virological Markers Associated With HBsAg Loss During Peginterferon Alpha-2a Treatment in HBeAg-Positive Chronic Hepatitis B Patien... by Minghui Li (409892)

    Published 2022
    “…HBsAg disappearance rate was the primary evaluation index at 48 weeks of PEG-IFN treatment.</p>Results<p>Among 100 patients who completed the 48-week PEG-IFN α-2a treatment, 38 patients achieved serum HBeAg disappearance, 25 patients achieved HBeAg seroconversion, 9 patients achieved functional cure, 37 patients had HBsAg decline of ≥1 log IU/ml, and 8 patients produced hepatitis B surface antibody (HBsAb). …”
  8. 12548

    Table 1_The evolution of the global disease burden of polycystic ovary syndrome and the role of regional heterogeneity in high body mass index exposure: a spatiotemporal analysis b... by Ying Feng (151159)

    Published 2025
    “…</p>Results<p>In 2021, the global age-standardized prevalence rate (ASPR) of PCOS was 867.7 per 100,000 [95% UI: 618.7–1,195.3], representing a significant increase of 0.75 compared with 1990 [95% CI: 0.71–0.78]. …”
  9. 12549

    Stimulus protocols. by Penelope A. McNulty (441014)

    Published 2013
    “…Self-sustained activity was evident in the right wrist extensors with both stimulus patterns, but not in the right thenar muscles. A: 25 Hz for 2 s then 100 Hz for 2 s then 25 Hz for 3 s, C: ramp stimulus, increasing from 1 Hz to 100 Hz over 5 s and then decreasing to 1 Hz over 5 s.…”
  10. 12550
  11. 12551

    IFNγ-induced inhibition of <i>C. trachomatis</i> growth in WT MEFs. by Munir A. Al-Zeer (266879)

    Published 2009
    “…The yield of <i>C. trachomatis</i> (B), but not <i>C. muridarum</i> (D), infectious progeny decreased considerably upon IFNγ stimulation, Infectivity percentage calculated as follows: IFU/ml estimated for each treated monolayer / IFU/ml of control cells ×100. …”
  12. 12552

    Forecast variation of ecoclimatic suitability between historical climate (current EI) and 2070 projected climate (future EI) from A2 climate scenarios using CSIRO-MK3.0 climate mod... by Sylvain Guichard (659128)

    Published 2014
    “…<p>a) qualitative variation highlighted the expansion (current EI = 0, future EI>0) and the contraction (current EI>0, future EI = 0) of suitable areas for 2070 projection. b) quantitative variation illustrated climatic suitability increases or decreases. …”
  13. 12553

    ConPADE: Genome Assembly Ploidy Estimation from Next-Generation Sequencing Data by Gabriel R. A. Margarido (725240)

    Published 2015
    “…<div><p>As a result of improvements in genome assembly algorithms and the ever decreasing costs of high-throughput sequencing technologies, new high quality draft genome sequences are published at a striking pace. …”
  14. 12554

    Histological (a, b, c) and immunohistological (d–i) stainings (CD3: d–f; HLA class I expression: g–i) of the EMBs at the initial presentation, at 6 and 12 months follow-up. by Mathias Streitz (33288)

    Published 2013
    “…The initially increased CD3<sup>+</sup> T-cells and HLA class I expression decreased at the follow-up EMBs. Original magnification a–f: 200×fold. …”
  15. 12555

    Inhibition of cilia disassembly protects RGCs and suppresses cell cycling after ONT. by Brian K. A. Choi (7114916)

    Published 2019
    “…Scale bar = 100 μm. (B) Quantification of RGCs after intravitreal injection of the TBA (n = 4 retinas) or AurA inhibitor I (n = 5 retinas), demonstrating significantly increased RGC survival at 14 days post-ONT compared to DMSO control treatment (**p<0.01). …”
  16. 12556

    Data Sheet 4_The global, regional, and national burden of colorectal cancer and its attributable risk factors in 204 countries and territories, 1990-2021: a systematic analysis for... by Shen Tian (4424170)

    Published 2025
    “…Between 1990 and 2021, the global age-standardized mortality rate (ASDR) decreased from 15.6 to 12.4 per 100,000, and the age-standardized DALY rate declined from 357.3 to 283.2 per 100,000. …”
  17. 12557

    Data Sheet 5_The global, regional, and national burden of colorectal cancer and its attributable risk factors in 204 countries and territories, 1990-2021: a systematic analysis for... by Shen Tian (4424170)

    Published 2025
    “…Between 1990 and 2021, the global age-standardized mortality rate (ASDR) decreased from 15.6 to 12.4 per 100,000, and the age-standardized DALY rate declined from 357.3 to 283.2 per 100,000. …”
  18. 12558

    Data Sheet 6_The global, regional, and national burden of colorectal cancer and its attributable risk factors in 204 countries and territories, 1990-2021: a systematic analysis for... by Shen Tian (4424170)

    Published 2025
    “…Between 1990 and 2021, the global age-standardized mortality rate (ASDR) decreased from 15.6 to 12.4 per 100,000, and the age-standardized DALY rate declined from 357.3 to 283.2 per 100,000. …”
  19. 12559

    Data Sheet 3_The global, regional, and national burden of colorectal cancer and its attributable risk factors in 204 countries and territories, 1990-2021: a systematic analysis for... by Shen Tian (4424170)

    Published 2025
    “…Between 1990 and 2021, the global age-standardized mortality rate (ASDR) decreased from 15.6 to 12.4 per 100,000, and the age-standardized DALY rate declined from 357.3 to 283.2 per 100,000. …”
  20. 12560

    Data Sheet 1_The global, regional, and national burden of colorectal cancer and its attributable risk factors in 204 countries and territories, 1990-2021: a systematic analysis for... by Shen Tian (4424170)

    Published 2025
    “…Between 1990 and 2021, the global age-standardized mortality rate (ASDR) decreased from 15.6 to 12.4 per 100,000, and the age-standardized DALY rate declined from 357.3 to 283.2 per 100,000. …”